Artelo Biosciences Stock Market Value
| ARTL Stock | USD 1.11 0.02 1.77% |
| Symbol | Artelo |
Artelo Biosciences Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Artelo Biosciences. If investors know Artelo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Artelo Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.87) | Return On Assets (0.54) | Return On Equity (0.89) |
The market value of Artelo Biosciences is measured differently than its book value, which is the value of Artelo that is recorded on the company's balance sheet. Investors also form their own opinion of Artelo Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Artelo Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Artelo Biosciences' market value can be influenced by many factors that don't directly affect Artelo Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Artelo Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Artelo Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Artelo Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Artelo Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Artelo Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Artelo Biosciences.
| 08/25/2024 |
| 11/23/2024 |
If you would invest 0.00 in Artelo Biosciences on August 25, 2024 and sell it all today you would earn a total of 0.00 from holding Artelo Biosciences or generate 0.0% return on investment in Artelo Biosciences over 90 days. Artelo Biosciences is related to or competes with Aileron Therapeutics, Curis, Salarius Pharmaceuticals, Vaccinex, Basilea Pharmaceutica, Ascletis Pharma, and Brii Biosciences. Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatmen... More
Artelo Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Artelo Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Artelo Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 26.32 | |||
| Value At Risk | (7.75) | |||
| Potential Upside | 7.83 |
Artelo Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Artelo Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Artelo Biosciences' standard deviation. In reality, there are many statistical measures that can use Artelo Biosciences historical prices to predict the future Artelo Biosciences' volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.86) | |||
| Treynor Ratio | (0.06) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Artelo Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Artelo Biosciences Backtested Returns
Artelo Biosciences secures Sharpe Ratio (or Efficiency) of -0.0198, which signifies that the company had a -0.0198% return per unit of risk over the last 3 months. Artelo Biosciences exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Artelo Biosciences' insignificant Risk Adjusted Performance, standard deviation of 4.98, and Mean Deviation of 3.48 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.24, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Artelo Biosciences will likely underperform. At this point, Artelo Biosciences has a negative expected return of -0.0994%. Please make sure to confirm Artelo Biosciences' treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Artelo Biosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.1 |
Very weak reverse predictability
Artelo Biosciences has very weak reverse predictability. Overlapping area represents the amount of predictability between Artelo Biosciences time series from 25th of August 2024 to 9th of October 2024 and 9th of October 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Artelo Biosciences price movement. The serial correlation of -0.1 indicates that less than 10.0% of current Artelo Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.1 | |
| Spearman Rank Test | -0.17 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Artelo Biosciences lagged returns against current returns
Autocorrelation, which is Artelo Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Artelo Biosciences' stock expected returns. We can calculate the autocorrelation of Artelo Biosciences returns to help us make a trade decision. For example, suppose you find that Artelo Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Artelo Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Artelo Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Artelo Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Artelo Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
Artelo Biosciences Lagged Returns
When evaluating Artelo Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Artelo Biosciences stock have on its future price. Artelo Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Artelo Biosciences autocorrelation shows the relationship between Artelo Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Artelo Biosciences.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Artelo Biosciences Correlation, Artelo Biosciences Volatility and Artelo Biosciences Alpha and Beta module to complement your research on Artelo Biosciences. For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Artelo Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.